Uniwersyteckie Centrum Onkologii Wum Sp. z o.o. (Poland)

Main Activities: All Other Miscellaneous Schools and Instruction

Secondary Activities: Department Stores | Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) | Ambulatory Health Care Services | Offices of Physicians | Offices of Dentists | Outpatient Care Centers | All Other Miscellaneous Ambulatory Health Care Services | General Medical and Surgical Hospitals

Full name: Uniwersyteckie Centrum Onkologii Wum Sp. z o.o.

Profile Updated: November 16, 2023

Uniwersyteckie Centrum Onkologii Wum Sp. z o.o. is based in Poland. The head office is in Warsaw. The company operates in the All Other Miscellaneous Schools and Instruction sector. The company was established on February 09, 2018. A growth of 526.26% was recorded in its total assets.

Headquarters
Ul. Zwirki I Wigury 61
Warsaw; Mazowieckie; Postal Code: 02-091

Contact Details: Purchase the Uniwersyteckie Centrum Onkologii Wum Sp. z o.o. report to view the information.

Basic Information

Registered Capital:

Purchase the Uniwersyteckie Centrum Onkologii Wum Sp. z o.o. report to view the information.

Financial Auditors:

Purchase the Uniwersyteckie Centrum Onkologii Wum Sp. z o.o. report to view the information.

Incorporation Date:

February 09, 2018

Company Performance

Financial values in the chart are available after Uniwersyteckie Centrum Onkologii Wum Sp. z o.o. report is purchased.

Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service

Key Financial Highlights

Annual growth percentages for latest two years in local currency PLN. Absolute financial data is included in the purchased report.

Operating Profit/Loss (EBIT)

-25632.94%▼

EBITDA

-25632.94%▼

Net Profit/Loss for the Period

-25632.94%▼

Total Assets

526.26%▲

Total Equity

499.88%▲

Return on Equity (ROE)

-134.68%▼